SB
IMMU

Suntrust Banks’s Immunomedics Inc IMMU Stock Holding History

Suntrust Banks’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$186K Sell
14,032
-2,055
-13% -$30.2K ﹤0.01% 1277
2019
Q2 		$223K Hold
16,087
– – ﹤0.01% 1225
2019
Q1 		$309K Buy
16,087
+787
+5% +$12.7K ﹤0.01% 1082
2018
Q4 		$218K Buy
15,300
+100
+0.7% +$1.99K ﹤0.01% 1158
2018
Q3 		$317K Hold
15,200
– – ﹤0.01% 1059
2018
Q2 		$360K Sell
15,200
-13,200
-46% -$265K ﹤0.01% 1031
2018
Q1 		$415K Hold
28,400
– – ﹤0.01% 954
2017
Q4 		$459K Hold
28,400
– – ﹤0.01% 897
2017
Q3 		$397K Buy
+28,400
New +$283K ﹤0.01% 957

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Suntrust Banks's IMMU Position: Q3 2019 in Review

Suntrust Banks reduced its Immunomedics Inc (IMMU) stake by 13% in Q3 2019, selling an estimated $30.2K and leaving 14,032 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #1277.

Suntrust Banks first reported a position in IMMU in Q3 2017 and has held it in 9 quarters since. The position peaked at $459K in Q4 2017. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • Suntrust Banks held 14,032 shares of Immunomedics Inc worth $186K as of Q3 2019.
  • Suntrust Banks sold 2,055 Immunomedics Inc shares in Q3 2019, an estimated $30.2K.
  • Immunomedics Inc made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1277 holding.
  • Suntrust Banks first reported a position in Immunomedics Inc in Q3 2017 and has held it in 9 quarters since.
  • Suntrust Banks's Immunomedics Inc position peaked at $459K in Q4 2017.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.